Tenax Therapeutics (TENX) Payables: 2011-2017
Historic Payables for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to $579,386.
- Tenax Therapeutics' Payables fell 58.39% to $579,386 in Q3 2017 from the same period last year, while for Sep 2017 it was $3.1 million, marking a year-over-year decrease of 36.07%. This contributed to the annual value of $727,599 for FY2016, which is N/A change from last year.
- Tenax Therapeutics' Payables amounted to $579,386 in Q3 2017, which was up 33.44% from $434,195 recorded in Q2 2017.
- Tenax Therapeutics' 5-year Payables high stood at $1.5 million for Q2 2016, and its period low was $434,195 during Q2 2017.
- In the last 3 years, Tenax Therapeutics' Payables had a median value of $972,483 in 2015 and averaged $1.0 million.
- As far as peak fluctuations go, Tenax Therapeutics' Payables spiked by 70.81% in 2013, and later tumbled by 71.46% in 2017.
- Quarterly analysis of 4 years shows Tenax Therapeutics' Payables stood at $1.0 million in 2013, then reached $972,483 in 2015, then fell by 25.18% to $727,599 in 2016, then crashed by 58.39% to $579,386 in 2017.
- Its Payables stands at $579,386 for Q3 2017, versus $434,195 for Q2 2017 and $1.4 million for Q1 2017.